BR J Cancer是由英国癌症研究基金会(Cancer Research UK)主办的一份国际性、同行评审的医学期刊。它创刊于上世纪中叶,致力于发表关于癌症流行病学、病因学、预防、诊断、治疗以及癌症患者护理等方面的最新研究成果和临床实践经验。该杂志以其高质量的研究论文、综述文章和病例报告,为全球癌症...
2024年11月24日,广东省教育厅临床精准用药重点实验室李雄教授团队在British Journal of Cancer(JCR分区Q1,中科院医学1区,广药大共识期刊B刊)在线发表了题为SKP2 Inhibition Activates Tumor Cell-Intrinsic Immunity by Inducing DNA Repl...
[科研必备] 专业SCI论文修改服务: ★先修改后付款; ☆语言问题免费重修; ★24-72小时交稿; ☆正规财务发票; ★一分钟下单; ☆365日不间断服务 Br J Cancer 英文杂志缩写 - British Journal of Cancer - 英文期刊全称 相关期刊: AACN Clinical Issues ...
Br J Cancer IF=8.8｜上海嘉因CUT&Tag、ATAC和ChIP-seq客户文章 2023年6月，山东大学第二医院王传新、山东大学齐鲁医院徐硕/展翰翔团队在British Journal of Cancer杂志上发表学术论文“Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of ...
近期,一项发表于《Br J Cancer》杂志的研究揭示了体重正常人群体脂成分与癌症发病风险之间的关系。该研究纳入了英国生物样本库(UK Biobank)中的149,928名体重正常(40-70岁)的个体,分析了肥胖与乳腺癌(绝经后)、子宫内膜癌、卵巢癌和结直肠癌发生风险的相关性。
HOLLIDAY R. A new theory of carcinogenesis. Br J Cancer 1979; 40:513-522.Holliday R: A new theory of carcinogenesis. Br J Cancer 40:513, 1979Holliday, R. (1979) A new theory of carcinogenesis. Br. J. Can. 40; 513–522.Holliday R. A new theory of carcinogenesis. Br J Cancer ...
Br. J. Cancer Summary.-Histological sections of the primary ttmour and of homolateral axillary lymph nodes from 500 women with operable invasive breast cancer have been examined. The tumours have been graded and the degree of round cell infiltration a... TD Bradshaw,S Wrigley,D Shi,... 被...
2023年6月,山东大学第二医院王传新、山东大学齐鲁医院徐硕/展翰翔团队在British Journal of Cancer杂志上发表学术论文“Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28”,阐明了KRAS驱动的Fos-like antigen 2 (FOSL2)通过转录激活C...
Br J Cancer 1985 ; 52: 99–103Adami HO, Holmberg L, Malker B, Ries L. Long-term survival in 406 males with breast cancer. Br J Cancer 1985; ... HO Adami,L Holmberg,B Malker,... - 《Br J Cancer》 被引量: 95发表: 1985年 Long-term survival in 406 males with breast cancer. ...
Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy. January 01, 2022 [MEDLINE Abstract] LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis. ...